Chargement en cours...
Minimal residual disease diagnostics in acute lymphoblastic leukemia: need for sensitive, fast, and standardized technologies
Monitoring of minimal residual disease (MRD) has become routine clinical practice in frontline treatment of virtually all childhood acute lymphoblastic leukemia (ALL) and in many adult ALL patients. MRD diagnostics has proven to be the strongest prognostic factor, allowing for risk group assignment...
Enregistré dans:
| Publié dans: | Blood |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society of Hematology
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490298/ https://ncbi.nlm.nih.gov/pubmed/25999452 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2015-03-580027 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|